Active substance
Technetium tc 99m pentetate kit
- US FDA 5
- Safety 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DRAXIMAGE DTPA | N/A | injectable · injection | JUBILANT | Prescription | 29 Dec 1989 |
| TECHNETIUM TC-99M PENTETATE KIT | N/A | injectable · injection | CURIUM | Prescription | 26 Mar 2025 |
| TECHNETIUM TC-99M PENTETATE KIT | N/A | injectable · injection | GE HEALTHCARE | Discontinued | 14 Feb 1974 |
| MPI DTPA KIT - CHELATE | N/A | injectable · injection | GE HEALTHCARE | Discontinued | 15 Apr 1976 |
| AN-DTPA | N/A | injectable · injection | JUBILANT DRAXIMAGE | Discontinued | 16 Nov 1976 |
Safety signals and safety-related labeling changes
- US FDA 7 Jun 2023 DRAXIMAGE DTPA — safety-related labeling change
Labeling sections changed: Adverse Reactions - US FDA 26 Dec 2017 DTPA — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.